Pub Date : 2025-11-12DOI: 10.1007/s11418-025-01963-x
Takayuki Ogi, Yasuhiro Kawano, Toru Usami, Idam Hermawan, Hiroto Yokaryo, Saori Yamamoto, Papawee Saiki
High levels of UV radiation in Okinawa contribute to skin damage, photoaging, and inflammation. Calophyllum inophyllum L. (Tamanu) trees are frequently cultivated along roadways in Okinawa. The oil isolated from Tamanu nuts is renowned for antioxidants, antibacterial, and anti-inflammatory properties. However, the specific UV-absorbing compounds responsible for its anti-inflammatory activity remain unidentified. This study aimed to isolate, characterize, and evaluate the anti-inflammatory activity of UV-absorbing components from Okinawan Tamanu oil. Clinical tests confirmed the UV-protective effects of Tamanu oil, with SPF and PA values of 6.3 ± 0.4 and 2.9 ± 0.6, respectively. UV-absorbing compounds were isolated based on absorbance at 300 nm and structurally characterized by mass spectrometry and NMR. The anti-inflammatory effects of calophyllolide (CAL), inocalophyllin A (ICA), and inocalophyllin B (ICB) were evaluated in LPS-stimulated RAW 264 macrophages and UVB-induced HaCaT keratinocytes. The specific absorbance at 300 nm of CAL, ICA, and ICB isolated from Tamanu oil (300 nm specific absorbance = 28) were = 695, 285, and 378, respectively. All three compounds significantly inhibited nitric oxide production in LPS-induced RAW 264 cells. CAL downregulated TNF-α, IL-1β, IL-6, and IL-1α, while ICA and ICB suppressed IL-1β, IL-6, and IL-1α. In UVB-stimulated HaCaT cells, all compounds reduced IL-1α production. ICA also suppressed TNF-α, HMGB1, and HDAC2, while ICB downregulated CASP1, BAX, NLRP3, HDAC1, and HDAC2 significantly. These findings suggest that CAL, ICA, and ICB have strong anti-inflammatory properties, with ICA and ICB providing additional protection against UVB-induced skin damage via inhibition of necroptosis and inflammatory signaling.
冲绳的高水平紫外线辐射会导致皮肤损伤、光老化和炎症。Calophyllum inophyllum L. (Tamanu)树在冲绳的公路沿线经常种植。从塔马努坚果中分离出来的油以抗氧化剂、抗菌和抗炎特性而闻名。然而,其抗炎活性的特定紫外线吸收化合物仍未确定。本研究旨在分离、表征和评价冲绳柽柳油中吸收紫外线成分的抗炎活性。临床试验证实了塔马努油的防紫外线作用,SPF值为6.3±0.4,PA值为2.9±0.6。利用300 nm吸光度分离得到吸收紫外的化合物,并用质谱和核磁共振对其结构进行了表征。在lps刺激的RAW 264巨噬细胞和uvb诱导的HaCaT角质形成细胞中,研究了calophyllide (CAL)、inocalophyllin A (ICA)和inocalophyllin B (ICB)的抗炎作用。从塔马努油中分离得到的CAL、ICA和ICB在300 nm处的比吸光度(比吸光度e1cm1 % = 28)分别为e1cm1 % = 695、285和378。这三种化合物均能显著抑制lps诱导的RAW 264细胞中一氧化氮的产生。CAL下调TNF-α、IL-1β、IL-6和IL-1α, ICA和ICB抑制IL-1β、IL-6和IL-1α。在uvb刺激的HaCaT细胞中,所有化合物都减少了IL-1α的产生。ICA还抑制TNF-α、HMGB1和HDAC2,而ICB则显著下调CASP1、BAX、NLRP3、HDAC1和HDAC2。这些发现表明,CAL、ICA和ICB具有很强的抗炎特性,ICA和ICB通过抑制坏死下垂和炎症信号传导,对uvb诱导的皮肤损伤提供额外的保护。
{"title":"Anti-inflammatory and UV-protective activities of isolated compounds from Calophyllum inophyllum L. in immune and skin cell models.","authors":"Takayuki Ogi, Yasuhiro Kawano, Toru Usami, Idam Hermawan, Hiroto Yokaryo, Saori Yamamoto, Papawee Saiki","doi":"10.1007/s11418-025-01963-x","DOIUrl":"https://doi.org/10.1007/s11418-025-01963-x","url":null,"abstract":"<p><p>High levels of UV radiation in Okinawa contribute to skin damage, photoaging, and inflammation. Calophyllum inophyllum L. (Tamanu) trees are frequently cultivated along roadways in Okinawa. The oil isolated from Tamanu nuts is renowned for antioxidants, antibacterial, and anti-inflammatory properties. However, the specific UV-absorbing compounds responsible for its anti-inflammatory activity remain unidentified. This study aimed to isolate, characterize, and evaluate the anti-inflammatory activity of UV-absorbing components from Okinawan Tamanu oil. Clinical tests confirmed the UV-protective effects of Tamanu oil, with SPF and PA values of 6.3 ± 0.4 and 2.9 ± 0.6, respectively. UV-absorbing compounds were isolated based on absorbance at 300 nm and structurally characterized by mass spectrometry and NMR. The anti-inflammatory effects of calophyllolide (CAL), inocalophyllin A (ICA), and inocalophyllin B (ICB) were evaluated in LPS-stimulated RAW 264 macrophages and UVB-induced HaCaT keratinocytes. The specific absorbance at 300 nm of CAL, ICA, and ICB isolated from Tamanu oil (300 nm specific absorbance <math><msubsup><mi>E</mi> <mrow><mn>1</mn> <mi>c</mi> <mi>m</mi></mrow> <mrow><mn>1</mn> <mo>%</mo></mrow> </msubsup> </math> = 28) were <math><msubsup><mi>E</mi> <mrow><mn>1</mn> <mi>c</mi> <mi>m</mi></mrow> <mrow><mn>1</mn> <mo>%</mo></mrow> </msubsup> </math> = 695, 285, and 378, respectively. All three compounds significantly inhibited nitric oxide production in LPS-induced RAW 264 cells. CAL downregulated TNF-α, IL-1β, IL-6, and IL-1α, while ICA and ICB suppressed IL-1β, IL-6, and IL-1α. In UVB-stimulated HaCaT cells, all compounds reduced IL-1α production. ICA also suppressed TNF-α, HMGB1, and HDAC2, while ICB downregulated CASP1, BAX, NLRP3, HDAC1, and HDAC2 significantly. These findings suggest that CAL, ICA, and ICB have strong anti-inflammatory properties, with ICA and ICB providing additional protection against UVB-induced skin damage via inhibition of necroptosis and inflammatory signaling.</p>","PeriodicalId":654,"journal":{"name":"Journal of Natural Medicines","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2025-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145494225","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-05DOI: 10.1007/s11418-025-01947-x
Canyi Li, Penghua Luo, Lin Tang, Yongqiang Yang, Long Rao, Lijun Zhong
This study aims to investigate the mechanism of action of BHLHE40 and its targeted drug, digoxin, in cervical cancer. The clinical significance of BHLHE40 was evaluated in cervical cancer samples using the UALCAN and Human Protein Atlas databases. The effects of BHLHE40 on proliferation, migration, invasion, and epithelial-mesenchymal transition (EMT) were then assessed through loss- and gain-of-function experiments coupled with CCK-8, wound healing, Transwell and Western blot analysis. A murine lung-metastasis model was further established to `validate the pro-metastatic role of BHLHE40 in vivo. JASPAR-based motif prediction, chromatin immunoprecipitation-qPCR (ChIP-qPCR), and luciferase reporter assays were employed to elucidate the transcriptional regulation of ANGPTL3 by BHLHE40. Molecular docking and cellular thermal shift assay (CETSA) were used to clarify the molecular interaction between digoxin and BHLHE40. BHLHE40 was markedly up-regulated in cervical cancer tissues and positively correlated with advanced tumor stage, lymph node metastasis, and poor prognosis. Knockdown of BHLHE40 suppressed proliferation, colony formation, migration, invasion, and attenuated EMT. Consistently, silencing BHLHE40 reduced the number of pulmonary metastatic nodules in nude mice. Mechanistically, BHLHE40 bound directly to the ANGPTL3 promoter and enhanced its transcriptional activity. Knock-down ANGPTL3 reversed BHLHE40-induced increases in migratory and invasive capacities as well as EMT-related phenotypic changes. Digoxin bound to the conserved domain of BHLHE40, down-regulated both BHLHE40 and ANGPTL3, and suppressed EMT and cell motility. Overexpression of BHLHE40 rescued these inhibitory effects of digoxin. Collectively, our findings demonstrate that BHLHE40 promotes EMT and metastasis in cervical cancer by transcriptionally activating ANGPTL3, whereas digoxin exerts anti-EMT effects by targeting this axis. These data highlight the critical role of the BHLHE40-ANGPTL3 axis in cervical cancer progression and suggest that repurposing digoxin offers a novel therapeutic strategy for suppressing EMT in this disease.
本研究旨在探讨BHLHE40及其靶向药物地高辛在宫颈癌中的作用机制。使用UALCAN和Human Protein Atlas数据库评估宫颈癌样本中BHLHE40的临床意义。BHLHE40对细胞增殖、迁移、侵袭和上皮-间质转化(EMT)的影响通过功能缺失和功能获得实验、CCK-8、伤口愈合、Transwell和Western blot分析来评估。进一步建立小鼠肺转移模型,验证BHLHE40在体内的促转移作用。采用基于jaspar的基序预测、染色质免疫沉淀- qpcr (ChIP-qPCR)和荧光素酶报告基因检测来阐明BHLHE40对ANGPTL3的转录调控作用。采用分子对接和细胞热移法(CETSA)研究地高辛与BHLHE40之间的分子相互作用。BHLHE40在宫颈癌组织中表达明显上调,与肿瘤分期、淋巴结转移、预后不良呈正相关。BHLHE40基因敲低可抑制细胞增殖、菌落形成、迁移、侵袭,并减弱EMT。同样,沉默BHLHE40可减少裸鼠肺转移结节的数量。从机制上讲,BHLHE40直接结合到ANGPTL3启动子上,增强了其转录活性。敲除ANGPTL3逆转bhlhe40诱导的迁移和侵袭能力的增加以及emt相关的表型变化。地高辛结合BHLHE40保守结构域,下调BHLHE40和ANGPTL3,抑制EMT和细胞运动。BHLHE40的过表达恢复了地高辛的抑制作用。总之,我们的研究结果表明BHLHE40通过转录激活ANGPTL3促进宫颈癌的EMT和转移,而地高辛通过靶向该轴发挥抗EMT作用。这些数据突出了BHLHE40-ANGPTL3轴在宫颈癌进展中的关键作用,并表明重新利用地高辛为抑制这种疾病的EMT提供了一种新的治疗策略。
{"title":"Digoxin targets BHLHE40 to inhibit epithelial-mesenchymal transition in cervical cancer cells via downregulation of ANGPTL3.","authors":"Canyi Li, Penghua Luo, Lin Tang, Yongqiang Yang, Long Rao, Lijun Zhong","doi":"10.1007/s11418-025-01947-x","DOIUrl":"https://doi.org/10.1007/s11418-025-01947-x","url":null,"abstract":"<p><p>This study aims to investigate the mechanism of action of BHLHE40 and its targeted drug, digoxin, in cervical cancer. The clinical significance of BHLHE40 was evaluated in cervical cancer samples using the UALCAN and Human Protein Atlas databases. The effects of BHLHE40 on proliferation, migration, invasion, and epithelial-mesenchymal transition (EMT) were then assessed through loss- and gain-of-function experiments coupled with CCK-8, wound healing, Transwell and Western blot analysis. A murine lung-metastasis model was further established to `validate the pro-metastatic role of BHLHE40 in vivo. JASPAR-based motif prediction, chromatin immunoprecipitation-qPCR (ChIP-qPCR), and luciferase reporter assays were employed to elucidate the transcriptional regulation of ANGPTL3 by BHLHE40. Molecular docking and cellular thermal shift assay (CETSA) were used to clarify the molecular interaction between digoxin and BHLHE40. BHLHE40 was markedly up-regulated in cervical cancer tissues and positively correlated with advanced tumor stage, lymph node metastasis, and poor prognosis. Knockdown of BHLHE40 suppressed proliferation, colony formation, migration, invasion, and attenuated EMT. Consistently, silencing BHLHE40 reduced the number of pulmonary metastatic nodules in nude mice. Mechanistically, BHLHE40 bound directly to the ANGPTL3 promoter and enhanced its transcriptional activity. Knock-down ANGPTL3 reversed BHLHE40-induced increases in migratory and invasive capacities as well as EMT-related phenotypic changes. Digoxin bound to the conserved domain of BHLHE40, down-regulated both BHLHE40 and ANGPTL3, and suppressed EMT and cell motility. Overexpression of BHLHE40 rescued these inhibitory effects of digoxin. Collectively, our findings demonstrate that BHLHE40 promotes EMT and metastasis in cervical cancer by transcriptionally activating ANGPTL3, whereas digoxin exerts anti-EMT effects by targeting this axis. These data highlight the critical role of the BHLHE40-ANGPTL3 axis in cervical cancer progression and suggest that repurposing digoxin offers a novel therapeutic strategy for suppressing EMT in this disease.</p>","PeriodicalId":654,"journal":{"name":"Journal of Natural Medicines","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2025-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145450517","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Rice-derived glucosylceramides (GlcCer) consist of multiple molecules that comprise different types of sphingoid bases and saturated fatty acids. These GlcCer are critical for epidermal barrier function and exert anti-melanogenic effects. Regarding their effects on the immune system, a dead cell-derived GlcCer [d18:2/24:1] was shown to enhance the activation of antigen-presenting cells via Mincle receptors. However, the immunomodulatory effects of rice-derived GlcCer have yet to be examined. Therefore, we herein investigated the effects of rice-derived GlcCer on dendritic cell (DC) activation. Among rice-derived GlcCer, GlcCer[d18:2(4E,8Z)/18:0] (10 μM) significantly enhanced IL-6 production by iMylc DC established from induced pluripotent stem cells. CD40 and CD80 expression was significantly upregulated by GlcCer[d18:2(4E,8Z)/18:0] in aMylc DC derived from human peripheral blood mononuclear cells. In a toll-like receptor (TLR) competitive binding assay using TLR antagonists, GlcCer[d18:2(4E,8Z)/18:0] bound to TLR2 and 4. The antigen-presenting abilities of GlcCer[d18:2(4E,8Z)/18:0] and GlcCer[d18:2(4E,8Z)/26:0] were confirmed by the mixed lymphocyte reaction test, which showed a significant T-cell proliferative effect. These results indicate that GlcCer[d18:2(4E,8Z)/18:0] activated DC being sensed by TLR2 and 4 and induced T-cell responses through the expression of CD40 and CD80. Therefore, the limited GlcCer molecules in rice appear to promote innate immune responses on DC.
{"title":"Rice-derived glucosylceramides activate innate immune responses in myeloid lineage differentiated dendritic cells via toll-like receptors 2 and 4.","authors":"Kenchi Miyasaka, Shogo Takeda, Ong Guang, Kiyoe Itoi, Kazuo Miyazaki, Yoshiaki Manse, Toshio Morikawa, Hiroshi Shimoda","doi":"10.1007/s11418-025-01951-1","DOIUrl":"https://doi.org/10.1007/s11418-025-01951-1","url":null,"abstract":"<p><p>Rice-derived glucosylceramides (GlcCer) consist of multiple molecules that comprise different types of sphingoid bases and saturated fatty acids. These GlcCer are critical for epidermal barrier function and exert anti-melanogenic effects. Regarding their effects on the immune system, a dead cell-derived GlcCer [d18:2/24:1] was shown to enhance the activation of antigen-presenting cells via Mincle receptors. However, the immunomodulatory effects of rice-derived GlcCer have yet to be examined. Therefore, we herein investigated the effects of rice-derived GlcCer on dendritic cell (DC) activation. Among rice-derived GlcCer, GlcCer[d18:2(4E,8Z)/18:0] (10 μM) significantly enhanced IL-6 production by iMylc DC established from induced pluripotent stem cells. CD40 and CD80 expression was significantly upregulated by GlcCer[d18:2(4E,8Z)/18:0] in aMylc DC derived from human peripheral blood mononuclear cells. In a toll-like receptor (TLR) competitive binding assay using TLR antagonists, GlcCer[d18:2(4E,8Z)/18:0] bound to TLR2 and 4. The antigen-presenting abilities of GlcCer[d18:2(4E,8Z)/18:0] and GlcCer[d18:2(4E,8Z)/26:0] were confirmed by the mixed lymphocyte reaction test, which showed a significant T-cell proliferative effect. These results indicate that GlcCer[d18:2(4E,8Z)/18:0] activated DC being sensed by TLR2 and 4 and induced T-cell responses through the expression of CD40 and CD80. Therefore, the limited GlcCer molecules in rice appear to promote innate immune responses on DC.</p>","PeriodicalId":654,"journal":{"name":"Journal of Natural Medicines","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2025-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145367340","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-17DOI: 10.1007/s11418-025-01962-y
Phan Thi Diem Tran, Vu Thi Thanh Tam, Tran Phuong Ha, Le Tuan Anh, Le Trung Hieu, Ton That Huu Dat, Le Canh Viet Cuong
Two new prunasines, bachmasides A and B (1-2), together with five known compounds, methyl 6-O-p-trans-coumaroyl-β-D-glucopyranoside (3), methyl 6-O-feruloyl-β-D-glucopyranoside (4), polystachyol (5), ethyl (6-O-p-hydroxybenzoyl)-β-D-glucopyranoside (6), and prunasin (7) were isolated from leaves of Elaeocarpus bachmaensis. The structures of isolated compounds (1-7) were elucidated by 1D-NMR, 2D-NMR, and HRMS spectra. The inhibition assays showed that compound 5 significantly inhibited α-amylase with IC50 value of 90.2 ± 11.5 µg/ml, whereas compounds 1, 2, 4 and 6 significantly inhibited α-glucosidase with IC50 values ranging from 42.4 ± 5.4 to 75.4 ± 5.6 µg/ml, considerably lower than those of acarbose (IC50 of 112.1 ± 3.1 and 133.0 ± 4.4 µg/ml, respectively). These findings suggest that E. bachmaensis may be a promising source of antidiabetic agents.
从bachmaensis Elaeocarpus叶片中分离到两个新的prunasines A和B(1-2),以及5个已知的化合物:甲基6- o -对反式香豆醇基-β- d -葡萄糖苷(3)、甲基6- o -阿魏酰-β- d -葡萄糖苷(4)、聚谷胱甘肽(5)、乙基(6- o -对羟基苯甲酰)-β- d -葡萄糖苷(6)和prunasin(7)。分离得到的化合物(1-7)的结构通过1D-NMR、2D-NMR和HRMS进行了表征。抑制实验表明,化合物5对α-淀粉酶的IC50值为90.2±11.5µg/ml,而化合物1、2、4和6对α-葡萄糖苷酶的IC50值为42.4±5.4 ~ 75.4±5.6µg/ml,显著低于阿卡波糖(IC50值分别为112.1±3.1和133.0±4.4µg/ml)。这些发现表明,巴赫马杆菌可能是一种有前景的抗糖尿病药物来源。
{"title":"New prunasin derivatives, bachmasides A and B, with α-glucosidase inhibitory activity from the leaves of Elaeocarpus bachmaensis.","authors":"Phan Thi Diem Tran, Vu Thi Thanh Tam, Tran Phuong Ha, Le Tuan Anh, Le Trung Hieu, Ton That Huu Dat, Le Canh Viet Cuong","doi":"10.1007/s11418-025-01962-y","DOIUrl":"https://doi.org/10.1007/s11418-025-01962-y","url":null,"abstract":"<p><p>Two new prunasines, bachmasides A and B (1-2), together with five known compounds, methyl 6-O-p-trans-coumaroyl-β-D-glucopyranoside (3), methyl 6-O-feruloyl-β-D-glucopyranoside (4), polystachyol (5), ethyl (6-O-p-hydroxybenzoyl)-β-D-glucopyranoside (6), and prunasin (7) were isolated from leaves of Elaeocarpus bachmaensis. The structures of isolated compounds (1-7) were elucidated by 1D-NMR, 2D-NMR, and HRMS spectra. The inhibition assays showed that compound 5 significantly inhibited α-amylase with IC<sub>50</sub> value of 90.2 ± 11.5 µg/ml, whereas compounds 1, 2, 4 and 6 significantly inhibited α-glucosidase with IC<sub>50</sub> values ranging from 42.4 ± 5.4 to 75.4 ± 5.6 µg/ml, considerably lower than those of acarbose (IC<sub>50</sub> of 112.1 ± 3.1 and 133.0 ± 4.4 µg/ml, respectively). These findings suggest that E. bachmaensis may be a promising source of antidiabetic agents.</p>","PeriodicalId":654,"journal":{"name":"Journal of Natural Medicines","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2025-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145312297","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
α-Glucosidase and α-amylase are two important glycosidases involved in carbohydrate metabolism. Inhibitors of these enzymes are considered crucial therapeutic agents for carbohydrate absorption disorders such as diabetes and obesity. However, the inhibition of salivary amylase can result in undigested starch reaching the stomach, causing indigestion and potentially leading to gastric and duodenal ulcers as well as gastritis. Selective inhibitors that possess α-glucosidase inhibitory activity without affecting α-amylase are needed to address this issue. It has been revealed that (+)-eupenoxide and its 3-ketone derivative, produced by the endophytic fungus of Aspergillus sp. C-1-1 strain associated with Catharanthus roseus, selectively inhibits α-glucosidase. Additionally, from the α-glucosidase inhibitory activity of related compounds, we have successfully deduced the chemical structure feature necessary for α-glucosidase inhibition.
α-葡萄糖苷酶和α-淀粉酶是参与碳水化合物代谢的两种重要糖苷酶。这些酶的抑制剂被认为是治疗碳水化合物吸收障碍如糖尿病和肥胖的关键药物。然而,唾液淀粉酶的抑制会导致未消化的淀粉到达胃,引起消化不良,并可能导致胃和十二指肠溃疡以及胃炎。需要具有α-葡萄糖苷酶抑制活性且不影响α-淀粉酶的选择性抑制剂来解决这一问题。研究表明,与玫瑰Catharanthus roseus相关的Aspergillus sp. c -1菌株内生真菌产生的(+)-真二烯氧化物及其3-酮衍生物具有选择性抑制α-葡萄糖苷酶的活性。此外,从相关化合物的α-葡萄糖苷酶抑制活性,我们成功地推断出α-葡萄糖苷酶抑制所必需的化学结构特征。
{"title":"Selective α-glucosidase inhibitory activity of (+)-eupenoxide and 3-ketone derivatives produced by the endophytic fungus of Aspergillus sp.","authors":"Shoji Maehara, Sachi Shibata, Chiho Takahara, Moeka Kumamoto, Yuhzo Hieda, Shogo Nakajima, Koichi Watashi, Toshiyuki Hata","doi":"10.1007/s11418-025-01964-w","DOIUrl":"https://doi.org/10.1007/s11418-025-01964-w","url":null,"abstract":"<p><p>α-Glucosidase and α-amylase are two important glycosidases involved in carbohydrate metabolism. Inhibitors of these enzymes are considered crucial therapeutic agents for carbohydrate absorption disorders such as diabetes and obesity. However, the inhibition of salivary amylase can result in undigested starch reaching the stomach, causing indigestion and potentially leading to gastric and duodenal ulcers as well as gastritis. Selective inhibitors that possess α-glucosidase inhibitory activity without affecting α-amylase are needed to address this issue. It has been revealed that (+)-eupenoxide and its 3-ketone derivative, produced by the endophytic fungus of Aspergillus sp. C-1-1 strain associated with Catharanthus roseus, selectively inhibits α-glucosidase. Additionally, from the α-glucosidase inhibitory activity of related compounds, we have successfully deduced the chemical structure feature necessary for α-glucosidase inhibition.</p>","PeriodicalId":654,"journal":{"name":"Journal of Natural Medicines","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2025-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145297980","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Carbazoles exhibit various pharmacological activities, including antitumor activity. Eustifoline-B is a carbazole from Murraya (Rutaceae) plants that exhibited strong antiproliferative activity against cancer stem cells (CSCs) that were established from a human glioblastoma (GBM) cell line (U-251 MG). This activity was stronger than that against GBM cells (non-CSCs), indicating that the activity was CSCs-selective. In this study, the efficacy of carbazole derivatives against GBM was evaluated, their structure–activity relationships were examined, and their blood–brain-barrier (BBB) permeability was investigated in vitro. First, 26 carbazole derivatives, two indole derivatives, and two quinoline derivatives were synthesized, including 12 new compounds. Next, 34 compounds, including the synthesized carbazole derivatives, were evaluated for their antiproliferative activities against U-251 MG CSCs and non-CSCs. Carbazoles with prenyl groups, including eustifoline-B, showed concentration-dependent antiproliferative activity against U-251 MG CSCs (IC50 = 3.5–19.8 µM). Among the prenyl groups, carbazole derivatives with geranyl groups, such as eustifoline-B and eustifoline-C, tended to have stronger activity against CSCs (IC50 = 6.2 µM and 3.5 µM) than that against non-CSCs (IC50 > 25 µM and IC50 = 6.6 µM), indicating that they are CSCs-selective. Finally, in vitro BBB permeability studies were performed using six carbazoles; most carbazoles, including eustifoline-C, exhibited BBB permeability. These results suggest the promising potential of carbazoles as new pharmaceutical agents for the treatment of GBM.
{"title":"Antiproliferative activity against glioblastoma-derived cancer stem cells and blood–brain-barrier permeability of carbazole derivatives from Murraya plants and related synthetic compounds","authors":"Kouta Ugawa, Raiki Yamamura, Kaori Yajima, Tomoe Ohta, Seikou Nakamura","doi":"10.1007/s11418-025-01956-w","DOIUrl":"10.1007/s11418-025-01956-w","url":null,"abstract":"<div><p>Carbazoles exhibit various pharmacological activities, including antitumor activity. Eustifoline-B is a carbazole from <i>Murraya</i> (Rutaceae) plants that exhibited strong antiproliferative activity against cancer stem cells (CSCs) that were established from a human glioblastoma (GBM) cell line (U-251 MG). This activity was stronger than that against GBM cells (non-CSCs), indicating that the activity was CSCs-selective. In this study, the efficacy of carbazole derivatives against GBM was evaluated, their structure–activity relationships were examined, and their blood–brain-barrier (BBB) permeability was investigated in vitro. First, 26 carbazole derivatives, two indole derivatives, and two quinoline derivatives were synthesized, including 12 new compounds. Next, 34 compounds, including the synthesized carbazole derivatives, were evaluated for their antiproliferative activities against U-251 MG CSCs and non-CSCs. Carbazoles with prenyl groups, including eustifoline-B, showed concentration-dependent antiproliferative activity against U-251 MG CSCs (IC<sub>50</sub> = 3.5–19.8 µM). Among the prenyl groups, carbazole derivatives with geranyl groups, such as eustifoline-B and eustifoline-C, tended to have stronger activity against CSCs (IC<sub>50</sub> = 6.2 µM and 3.5 µM) than that against non-CSCs (IC<sub>50</sub> > 25 µM and IC<sub>50</sub> = 6.6 µM), indicating that they are CSCs-selective. Finally, in vitro BBB permeability studies were performed using six carbazoles; most carbazoles, including eustifoline-C, exhibited BBB permeability. These results suggest the promising potential of carbazoles as new pharmaceutical agents for the treatment of GBM.</p><h3>Graphical Abstract</h3><div><figure><div><div><picture><source><img></source></picture></div></div></figure></div></div>","PeriodicalId":654,"journal":{"name":"Journal of Natural Medicines","volume":"79 6","pages":"1361 - 1371"},"PeriodicalIF":2.5,"publicationDate":"2025-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145298065","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The human gastrointestinal tract harbors over a thousand coexisting bacterial species that together constitute a highly complex intestinal microbiome. Dysbiosis of this microbial ecosystem has been implicated in the pathogenesis of disorders such as ulcerative colitis and obesity and has driven the development of microbiota-targeted prevention and treatment strategies. Traditional Kampo medicines are used with the aim of restoring the balance of the whole body, having been developed and established uniquely in Japan based on traditional Chinese medicine with a history of over two millennia. Recent evidence has revealed that the gut microbiota plays critical roles in the pharmacological effects of traditional Kampo medicines. For example, the anti-obesity activity of Bofutsushosan has been linked to an increase in Akkermansia muciniphila. The laxative effect of Daiokanzoto is related to rheinanthrone, which is produced from sennoside A through the gut microbiota, and drugs and foods that can alter the gut microbiota change the laxative activity of Daiokanzoto. In recent years, clinical trials have been conducted to examine the relationship between changes in the gut microbiota and the pharmacological effects of Kampo medicines, and this relationship has come to the forefront. This review discusses the findings of basic and clinical research on the role of the gut microbiota in the pharmacological action of traditional Kampo medicines, focusing on Bofutsushosan, Daiokanzoto, Daikenchuto, and Hangeshashinto, and discusses future issues and prospects for research into these interactions.
{"title":"Role of the gut microbiota in the pharmacological effects of traditional Kampo medicine and natural products","authors":"Nobutomo Ikarashi, Risako Kon, Hiroyasu Sakai, Tomoo Hosoe","doi":"10.1007/s11418-025-01959-7","DOIUrl":"10.1007/s11418-025-01959-7","url":null,"abstract":"<div><p>The human gastrointestinal tract harbors over a thousand coexisting bacterial species that together constitute a highly complex intestinal microbiome. Dysbiosis of this microbial ecosystem has been implicated in the pathogenesis of disorders such as ulcerative colitis and obesity and has driven the development of microbiota-targeted prevention and treatment strategies. Traditional Kampo medicines are used with the aim of restoring the balance of the whole body, having been developed and established uniquely in Japan based on traditional Chinese medicine with a history of over two millennia. Recent evidence has revealed that the gut microbiota plays critical roles in the pharmacological effects of traditional Kampo medicines. For example, the anti-obesity activity of Bofutsushosan has been linked to an increase in <i>Akkermansia muciniphila</i>. The laxative effect of Daiokanzoto is related to rheinanthrone, which is produced from sennoside A through the gut microbiota, and drugs and foods that can alter the gut microbiota change the laxative activity of Daiokanzoto. In recent years, clinical trials have been conducted to examine the relationship between changes in the gut microbiota and the pharmacological effects of Kampo medicines, and this relationship has come to the forefront. This review discusses the findings of basic and clinical research on the role of the gut microbiota in the pharmacological action of traditional Kampo medicines, focusing on Bofutsushosan, Daiokanzoto, Daikenchuto, and Hangeshashinto, and discusses future issues and prospects for research into these interactions.</p><h3>Graphical abstract</h3><div><figure><div><div><picture><source><img></source></picture></div></div></figure></div></div>","PeriodicalId":654,"journal":{"name":"Journal of Natural Medicines","volume":"79 6","pages":"1447 - 1454"},"PeriodicalIF":2.5,"publicationDate":"2025-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145273326","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-06DOI: 10.1007/s11418-025-01950-2
Tomoyo Nishida, Shinichiro Sawa, Koji Sugimura
Glycyrrhiza is a crude drug used worldwide, especially in China and Japan. Glycyrrhiza uralensis Fischer and Glycyrrhiza glabra L. are listed as original plants in the 18th revised Japanese Pharmacopoeia; however, G. uralensis is considered the most important Glycyrrhiza species because it has traditionally been used medicinally. Most G. uralensis used in Japan is imported from China, but export restrictions in recent years have raised concerns about stable supply. Therefore, domestic cultivation in Japan is expected to prevent price increases of raw materials and ensure a stable supply. Accurate species identification is an important step in quality control. In recent years, a method for identifying species using molecular markers has been evaluated for the Glycyrrhiza genus; however, in this study, we found that a simpler method, PCR–RFLP, using two types of restriction enzymes, can be used to identify G. uralensis more cheaply and easily than conventional methods. When applied to the ITS1-5.8S-ITS2 region, the analysis of seeds distributed in the market showed that only four of the 190 seeds surveyed were G. uralensis, while most were G. glabra, G. inflata, or their hybrids. Therefore, to appropriately use commercially available G. uralensis seeds, it is important to correctly identify the species at an early stage. Quick identification using PCR–RFLP is thought to be a useful method for ensuring the adequate supply of G. uralensis.
{"title":"Development of a low-cost, simple, and rapid identification method for Glycyrrhiza uralensis using PCR–RFLP and evaluation of seeds distributed on the market","authors":"Tomoyo Nishida, Shinichiro Sawa, Koji Sugimura","doi":"10.1007/s11418-025-01950-2","DOIUrl":"10.1007/s11418-025-01950-2","url":null,"abstract":"<div><p>Glycyrrhiza is a crude drug used worldwide, especially in China and Japan. <i>Glycyrrhiza uralensis</i> Fischer and <i>Glycyrrhiza glabra</i> L. are listed as original plants in the 18th revised Japanese Pharmacopoeia; however, <i>G. uralensis</i> is considered the most important <i>Glycyrrhiza</i> species because it has traditionally been used medicinally. Most <i>G. uralensis</i> used in Japan is imported from China, but export restrictions in recent years have raised concerns about stable supply. Therefore, domestic cultivation in Japan is expected to prevent price increases of raw materials and ensure a stable supply. Accurate species identification is an important step in quality control. In recent years, a method for identifying species using molecular markers has been evaluated for the <i>Glycyrrhiza</i> genus; however, in this study, we found that a simpler method, PCR–RFLP, using two types of restriction enzymes, can be used to identify <i>G. uralensis</i> more cheaply and easily than conventional methods. When applied to the <i>ITS</i>1-5.8S-<i>ITS</i>2 region, the analysis of seeds distributed in the market showed that only four of the 190 seeds surveyed were <i>G. uralensis</i>, while most were <i>G. glabra</i>, <i>G. inflata</i>, or their hybrids. Therefore, to appropriately use commercially available <i>G. uralensis</i> seeds, it is important to correctly identify the species at an early stage. Quick identification using PCR–RFLP is thought to be a useful method for ensuring the adequate supply of <i>G. uralensis</i>.</p><h3>Graphical Abstract</h3><div><figure><div><div><picture><source><img></source></picture></div></div></figure></div></div>","PeriodicalId":654,"journal":{"name":"Journal of Natural Medicines","volume":"79 6","pages":"1419 - 1432"},"PeriodicalIF":2.5,"publicationDate":"2025-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s11418-025-01950-2.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145237641","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Acute lung injury (ALI) remains a critical inflammatory condition with limited therapeutic interventions. This study explores the anti-inflammatory potential of calycosin (CAL), a bioactive flavonoid, in lipopolysaccharide (LPS)-induced MH-S alveolar macrophages cell line, with particular focus on macrophage polarization mechanisms. Through CCK-8 cytotoxicity assessment and subsequent experimental grouping (control, LPS, and LPS + CAL), we demonstrated CAL’s ability to significantly suppress LPS-triggered inflammatory mediators including IL-1β, TNF-α, and IL-6 at both transcriptional and protein levels. Flow cytometric analysis revealed CAL’s dual regulatory effect on macrophage polarization markers, downregulating M1-associated CD86 while enhancing M2-related CD206 expression. Transcriptomic profiling identified 5,944 differentially expressed genes in LPS-stimulated cells enriched in TNF signaling pathways, while CAL treatment specifically modulated 83 genes predominantly involved in TGF-β signaling. Mechanistic investigations identified Spon2 as a critical mediator, where CAL-induced Spon2 downregulation attenuated inflammation and promoted M2 polarization, effects corroborated through Spon2-shRNA knockdown and overexpression experiments. Notably, we newly demonstrate that Spon2 overexpression abolishes CAL-mediated suppression of TNF-α and activation of TGF-β/Smad2 signaling. These findings collectively establish CAL as a promising therapeutic candidate for ALI through its Spon2-mediated modulation of macrophage polarization dynamics.